Podcasts about commercial operations

This is episode 836. Read the complete transcription on the Sales Game Changers Podcast website. This is an AI and Selling Effectiveness sub-brand of the Sales Game Changers Podcast. Watch the video of this podcast on YouTube here. The Sales Game Changers Podcast was recognized by YesWare as the top sales podcast. Read the announcement here. FeedSpot named the Sales Game Changers Podcast at a top 20 Sales Podcast and top 8 Sales Leadership Podcast! Subscribe to the Sales Game Changers Podcast now on Apple Podcasts! Purchase Fred Diamond's best-sellers Love, Hope, Lyme: What Family Members, Partners, and Friends Who Love a Chronic Lyme Survivor Need to Know and Insights for Sales Game Changers now! On today's show, Fred meets with Stephanie Jordan, Vice President of Sales and Commercial Operations at World Fuel Services and recipient of the AI & Selling Effectiveness Award at this year's IEPS Annual Sales Excellence Awards. Find Stephanie on LinkedIn. STEPHANIE'S TIP: "AI should be used to eliminate the friction in your sales process so you can focus on what actually matters. The goal is not to replace the relationship, it's to give sellers more time to build it and move the deal forward in a meaningful way."

Send us Fan MailExploring whether nonprofits should pay taxes on business income, examining how revenue sources, competition, and policy gaps are reshaping the sector's financial landscape.Nonprofit tax exemption business income is becoming one of the most important—and controversial—issues facing the sector today. As nonprofits generate more revenue through business-like activities, the question is no longer theoretical: should some of that income be taxed?In this eye-opening conversation, Scott Hodge of Arnold Ventures joins The Nonprofit Show to examine how nonprofit revenue models have evolved—and where the current tax framework may no longer align with reality.The nonprofit sector now represents $3.6 trillion in total revenue, with approximately $2.8 trillion coming from business-related activities. Yet much of this income remains untaxed. As Scott explains, “We have this enormous… gap in the tax code so that these businesses that are now nonprofits are not paying any tax on their business income.”This raises real operational and strategic questions for nonprofit leaders. When organizations generate revenue through sponsorships, services, or large-scale operations, where is the line between mission-driven funding and commercial activity?The discussion also revisits the intent behind the Unrelated Business Income Tax (UBIT) and why it may no longer capture the realities of today's nonprofit economy. “UBIT has been made so full of holes that it doesn't capture very much income at all,” Scott notes.At the same time, the conversation carefully distinguishes between truly charitable organizations—those driven primarily by donations—and large-scale entities operating with minimal philanthropic income. This distinction matters, especially as nonprofits compete not only with for-profit businesses but also with each other for limited donor dollars.For nonprofit executives, finance leaders, and board members, this episode offers a critical lens on:Revenue strategy and risk exposurePolicy shifts that could impact operationsThe long-term sustainability of tax-exempt statusThis isn't about weakening the sector—it's about understanding how definitions, funding models, and accountability may evolve in the years ahead.  00:00:00 Introduction: Should Nonprofits Pay Taxes? 00:01:20 The Scale of the Nonprofit Economy 00:04:30 What Counts as “Business Income”? 00:06:45 Real Examples: NCAA, AARP, Hospitals 00:09:20 Understanding UBIT and Its Limitations 00:12:00 Nonprofit Survival vs Business Activity 00:14:10 Defining True Charity vs Commercial Operations 00:16:00 Where Large Nonprofits Blur the Lines 00:20:00 Sector Pressure and Public Perception 00:22:30 Why Policy Change Has Stalled 00:24:00 What Could Trigger Reform? 00:26:00 Final Thoughts: Protecting True Charitable Work #TheNonprofitShow #NonprofitTaxation #NonprofitFinanceFind us Live daily on YouTube!Find us  Live daily on LinkedIn!Find us Live daily on X: @Nonprofit_ShowOur national co-hosts and amazing guests discuss management, money and missions of nonprofits!  12:30pm ET   11:30am CT  10:30am MT  9:30am PTSend us your ideas for Show Guests or Topics: HelpDesk@AmericanNonprofitAcademy.comVisit us on the web:The Nonprofit Show

Recorded live from HOSPA edinburgh event Next Wave Hospitality: Tech Transformation that delivers sponsored by Focus on Hospitality withMike Baxtor, House of Gods Barry Makin, GM, Cromlix HotelLorraine Garvie, Head of Commercial Operations, Crieff HydroWe get their take on the changes in hospitality and guest experiences, what it will take to stand out and how they're addressing tech and digital transformation.We askHow are hospitality perceptions shifting for your business?Where is the role of AI and automation both in operations and guest experience?With IT infrastructure changing quickly, where's your focus?Where's the line of digitalised guest journeys to human?

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Alessandro Maselli, President and Chief Executive Officer at Catalent and Franco Negron is the Chief Executive Officer at Simtra BioPharma Solutions.   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology ecosystem with his esteemed guests during a live fireside chat at the DCAT Morgan Stanley CDMO CEO Dinner.   Alessandro Maselli is the President and Chief Executive Officer of Catalent, having assumed the CEO role in July 2022 after serving as the company's President and Chief Operating Officer since February 2019.  He has been with Catalent since 2010 and has played a central role in shaping the company into one of the world's leading contract development and manufacturing organizations serving pharmaceutical, biotechnology, and consumer health customers globally.   Alessandro joined Catalent as Director of Operations at the company's pharmaceutical, nutrition, and cosmetics facility in Italy. Over the course of more than a decade, he progressed through a series of increasingly senior leadership roles, including General Manager of the Zydis® operations in Swindon, U.K., Vice President of Operations for Europe within the Drug Delivery Solutions business, and Senior Vice President of Global Operations. In these roles, he oversaw multi-site global manufacturing networks, large-scale capacity expansions, and complex technology platforms across oral solid dose, biologics, and advanced delivery modalities.   As Chief Executive Officer, Alessandro led Catalent through the COVID-19 pandemic, during which the company played a critical role in the global response by supporting vaccine and therapeutic manufacturing at unprecedented scale. More recently, he has overseen Catalent's transition to private ownership following its $16.5 billion acquisition by Novo Holdings, positioning the company for long-term investment and growth as a privately held global CDMO.   Prior to joining Catalent, Mr. Maselli held a range of operational and business leadership roles at ABB Group, Alstom, and SGS, gaining extensive experience in industrial automation, engineering, and large-scale manufacturing operations. He began his career as an automation systems engineer in the food industry. In addition to his executive role, Alessandro serves on the Board of Directors of Graphic Packaging Holding Company, to which he was appointed in May 2025. He holds bachelor's and master's degrees in electronic engineering from the University of Rome and is a native of Italy.   Franco Negron is the Chief Executive Officer of Simtra BioPharma Solutions, a leading sterile injectable contract development and manufacturing organization formed following the divestiture of Baxter International's BioPharma Solutions business. He was appointed CEO in 2023 by Advent International and Warburg Pincus to lead the business as an independent, private-equity-backed CDMO focused on clinical-to-commercial parenteral manufacturing. Franco is an industry veteran with nearly 30 years of pharmaceutical and biopharmaceutical experience, bringing deep expertise across sterile manufacturing, commercial operations, and global supply chain leadership. Prior to joining Simtra, he served as Chief Executive Officer of ApiJect Systems America, a medical technology company focused on advanced drug-delivery and injection systems. Earlier in his career, he held senior executive roles at Thermo Fisher Scientific, where he served as President of Commercial Operations, and at Patheon Pharmaceuticals, where he was President of Development and Commercial Operations, North America, playing a key role in scaling Patheon's CDMO platform prior to its $7.2 billion acquisition by Thermo Fisher in 2017.   Franco has also held leadership positions at several major pharmaceutical companies, including Vice President of Manufacturing and Supply at Valeant Pharmaceuticals, Global Vice President within Novartis' Consumer Health division, and Site General Manager at McNeil Consumer Healthcare.   Across these roles, he developed a reputation for operational excellence, customer-centric leadership, and the ability to lead complex manufacturing organizations through periods of transformation and growth. As CEO of Simtra, Franco is leading the company through its next phase of expansion, focused on strengthening its sterile fill-finish capabilities, advancing technical differentiation, and investing in capacity to support increasing demand for injectable biologics, vaccines, and complex parenteral products   Molecule to Market is also sponsored by Bora Pharmaceuticals, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating!

In this episode of Humans of Agriculture, we sit down with Jack Ternouth, Head of Commercial Operations at Zentera (formerly New Zealand Merino Company), for a conversation that captures what's possible when curiosity, grit, and opportunity collide in agriculture.Jack didn't grow up on a farm, but through sheer determination and a willingness to learn, he's built a career from the ground up in one of the most complex and globally connected parts of the ag industry. From classing wool and working alongside growers to now leading commercial conversations with global brands, his journey is a powerful example of what's possible in ag today.On this episode, we explore what it takes to build a career in agriculture without a traditional background, the critical role of mentorship, and why value creation - not scale - is the future for countries like Australia and New Zealand. Jack also shares how Zentera is helping create more certainty for growers in a volatile market through traceability, long-term contracts, and global brand partnerships.This episode is about ambition, learning on the go, and the next generation shaping agriculture's future.Key insights from the conversation:Jack Ternouth's journey from outsider to commercial leader in the wool industryWhy curiosity, hunger, and alignment matter more than backgroundThe power of mentorship in accelerating a career in agricultureHow Zentera is creating stability for growers in volatile marketsWhy storytelling still matters in a data-driven worldThe shift from commodity to value-added agricultureThe importance of traceability, certification, and global consumer trustOpportunities for young people to build careers in ag without farming rootsChapters:00:00 Intro & Why This Conversation Matters01:48 Jack's Background: From Zimbabwe to New Zealand04:10 Starting at NZ Merino & Learning the Wool Industry06:30 Moving Into Commercial & Global Brand Relationships08:05 Advice for Young People Entering Agriculture09:40 Learning the Industry Without a Farming Background11:30 Storytelling vs Data in Modern Agriculture12:45 Zentera's Growth & Global Strategy14:40 Certifications, Traceability & Market Access16:20 Supporting Growers & Moving Away from Mulesing18:10 Volatility, Contracts & Creating Certainty20:15 The Future of Wool & Global Demand22:10 Long-Term Vision for the Industry24:10 Opportunities for the Next Generation in Ag25:45 Wrap Up

Alicia Hickey is an unapologetically smart, confident, and skilled women from DePaul's Department of Economics MS-EPA program. She joins us this month to talk about how she built a successful career and to give thanks to those who helped her fully embrace her abilities and intelligence. Alicia is currently Director of Commercial Operations, North America, at the European energy giant Uniper and oversees a team charged with managing complex trade operations in the energy markets. Her current position and responsibilities are the result of her choices in education, work experience and the strong women that helped guide her forward. You have to listen to this one. 

Andria Parks, Head of Commercial Operations at First Ascent Biomedical, highlights the value of using a biopsy to grow cancer cells in a lab to determine which drugs are most likely to be effective against a specific cancer. This functional medicine approach combines lab data, genomic data, and AI to produce a report that identifies which drugs might work and which are unlikely to be effective for that individual patient. This perspective is particularly effective for rare cancers, which often lack established treatment guidelines.  Andria explains, "First Ascent Biomedical is a functional precision medicine company. And what that means is we've put together three very unique and advanced technologies to produce something very specific, and I'll explain what that means. What we do is we take a fresh biopsy from a patient, and we will grow those cells in our lab in a medium very similar to the human body. We will test or validate more than 150 drugs and drug combinations on those cells to see what works on those cells and what kills them. We will combine that with a patient's genomic information using our advanced AI. And then a report is produced that stack ranks the drugs that work, but most importantly, the drugs that don't work for that patient's cancer. And when a physician sees that report, they know exactly what to start with before initiating treatment. So everything we do is outside the body."   "If you are testing 150 drugs and combinations on your unique cancer cells, you will be able to know what works and doesn't ahead of time. Usually, most patients who don't follow this approach go through a standard-of-care protocol. And what that means is these protocols or ways of treating patients are based on hundreds of thousands of patients that may look like you and me, but are not you and me. So it's based on evidence of many, many, many patients with a similar type of profile. But the uniqueness of getting a drug to work for your specific cancers is based on your unique cells. So that's what makes a big difference. You may see 20% - 40% that works, but without knowing if they were tested on your cancer cells, and that's what makes a big difference with what functional precision medicine in oncology delivers." #FirstAscentBiomedical #PrecisionMedicine #CancerResearch #Oncology #PersonalizedMedicine #HealthTech #RareCancer #Innovation #FunctionalMedicine #AI #Biotech #PatientCare firstascentbiomedical.com Download the transcript here

Andria Parks, Head of Commercial Operations at First Ascent Biomedical, highlights the value of using a biopsy to grow cancer cells in a lab to determine which drugs are most likely to be effective against a specific cancer. This functional medicine approach combines lab data, genomic data, and AI to produce a report that identifies which drugs might work and which are unlikely to be effective for that individual patient. This perspective is particularly effective for rare cancers, which often lack established treatment guidelines.  Andria explains, "First Ascent Biomedical is a functional precision medicine company. And what that means is we've put together three very unique and advanced technologies to produce something very specific, and I'll explain what that means. What we do is we take a fresh biopsy from a patient, and we will grow those cells in our lab in a medium very similar to the human body. We will test or validate more than 150 drugs and drug combinations on those cells to see what works on those cells and what kills them. We will combine that with a patient's genomic information using our advanced AI. And then a report is produced that stack ranks the drugs that work, but most importantly, the drugs that don't work for that patient's cancer. And when a physician sees that report, they know exactly what to start with before initiating treatment. So everything we do is outside the body."   "If you are testing 150 drugs and combinations on your unique cancer cells, you will be able to know what works and doesn't ahead of time. Usually, most patients who don't follow this approach go through a standard-of-care protocol. And what that means is these protocols or ways of treating patients are based on hundreds of thousands of patients that may look like you and me, but are not you and me. So it's based on evidence of many, many, many patients with a similar type of profile. But the uniqueness of getting a drug to work for your specific cancers is based on your unique cells. So that's what makes a big difference. You may see 20% - 40% that works, but without knowing if they were tested on your cancer cells, and that's what makes a big difference with what functional precision medicine in oncology delivers." #FirstAscentBiomedical #PrecisionMedicine #CancerResearch #Oncology #PersonalizedMedicine #HealthTech #RareCancer #Innovation #FunctionalMedicine #AI #Biotech #PatientCare firstascentbiomedical.com  Listen to the podcast here

Host: Annik Sobing Guest: Kenneth G. Peters Published: February 2026 Length: ~20 minutes Presented by: Global Training Center GTM Software Prep: Don't Install Until You've Done These 3 Things First In this Simply Trade Roundup, Annik talks with Kenneth G. Peters, President at MIC US and Director of Commercial Operations in North America, about Global Trade Management (GTM) software—specifically, what trade teams must do before implementation to avoid creating “digital chaos.” Ken shares real talk from his ATCC presentation on data cleanup, process mapping, and testing, plus why “cleaning your data like you're hosting the in-laws” is now his signature advice. Shoutout to Alison for the killer slides.​ What You'll Learn in This Episode Ken's new grandpa status (the little guy is 7 months old—congrats!) and why it's the “next step in life” that keeps him energized for trade tech.​ The #1 mistake companies make with GTM software Data cleanup first: Don't dump junk into GTM. Scrub inactive vendors, obsolete parts, invalid HS codes (like 111111 or all zeros). Clean it like you're hosting the in-laws—no mess allowed. Why: GTM amplifies what you give it. Bad data in = faster mistakes out.​ Avoid the “Big Bang” implementation trap Don't try to do everything at once (denied party screening + classification + FTA rules + solicitation). Start small: Classification (builds the foundation—parts, HS codes, values). Denied party screening (uses your vendor/part data). FTA analysis (relies on classification/HS from step 1). Why: Master data dependencies mean you build once and reuse everywhere.​ Processes over pixels GTM won't fix broken workflows. Map your processes before going live. If your current setup is emailing Excel files between systems, you're not automating—you're digitizing chaos. True automation: ERP ↔ GTM via SFTP, APIs, XML—no human hands on keyboards. Reduces errors, speeds everything up.​ Who owns what after go‑live MIC US (GTM provider): Manages the software backend—reg updates, HS databases, platform maintenance. Your team: Owns the process (classification, entry creation, decision‑making). Someone still reviews outputs for accuracy. No “managed services” from MIC—GTM is a tool, not a full‑service outsource.​ Testing: where most implementations fail Allocate real time and resources to testing—don't rush it. Test end‑to‑end: data flow, workflows, edge cases. Why: Skipped or rushed testing = live problems that cost more to fix later.​ “If your systems are emailing Excel files to each other, you're not automating” Ken's golden rule: Hands‑off data flow (ERP → GTM) eliminates errors. Excel handoffs = manual errors waiting to happen.​ Key Takeaways Clean data first: Active parts, valid HS, no ghosts—GTM makes good data shine and bad data explode.​ Start small, build smart: Classification → screening → FTA, not “big bang everything.”​ Fix processes before pixels: GTM won't save broken workflows; it speeds them up.​ Testing = non‑negotiable: Rushed testing = expensive live fixes.​ GTM is a force multiplier—if your foundation is solid.​ Credits Host: Annik Sobing Guest: Kenneth G. Peters, President, MIC US Producer: Annik Sobing  Listen & Subscribe Simply Trade main page: https://simplytrade.podbean.com​ Apple Podcasts: https://podcasts.apple.com/us/podcast/simply-trade/id1640329690​ Spotify: https://open.spotify.com/show/09m199JO6fuNumbcrHTkGq​ Amazon Music: https://music.amazon.com/podcasts/8de7d7fa-38e0-41b2-bad3-b8a3c5dc4cda/simply-trade​ Connect with Simply Trade Podcast page: https://www.globaltrainingcenter.com/simply-trade-podcast​ LinkedIn: https://www.linkedin.com/showcase/simply-trade-podcast​ YouTube: https://www.youtube.com/@SimplyTradePod​ Join the Trade Geeks Community Trade Geeks (by Global Training Center): https://globaltrainingcenter.com/trade-geeks/  

For 30 years, the AOP Health Group has been dedicated to developing innovative solutions to address unmet medical needs, particularly in the fields of rare diseases and intensive care medicine, and notably in cardiology and pulmonology, as well as haemato-oncology and advanced therapies. As Rare Disease Day approaches, in a special episode of the pharmaphorum podcast, sponsored by AOP Health, we spoke with Melissa Fellner, VP of Global Therapeutic Areas, Commercial Operations, at AOP Health, to discuss AOP Health's work in the rare disease space. Fellner describes the unique challenges faced in R&D in the rare disease space, as well as how advanced therapies are changing the treatment landscape, and what the future could hold, in terms of technological innovation and personalisation. What becomes clear is the key role that collaboration plays, from the very early stages of clinical trial design and beyond. You can listen to episode 246 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from. About the interviewee Melissa Fellner is Vice President of Global Therapeutic Areas at AOP Health. She holds a Master's in Biology, as well as an MBA from The Rady School of Management at University of California, San Diego. Fellner brings more than 25 years of experience across research, clinical development, commercialisation, and global marketing within the pharmaceutical industry. She began her career in 2000 as a research scientist and moved into clinical trial research in the United States and Canada in 2004 with a global contract research organisation. In 2009, Fellner transitioned into commercialisation consulting, partnering with large pharmaceutical companies on market access and launch strategy. She joined MedImmune, part of AstraZeneca, in 2012 as manager of access services operations, marking her move into the biopharmaceutical industry. In 2017, Fellner advanced into AstraZeneca's commercial organisation, serving as associate director of consumer marketing for respiratory biologics and later as global marketing director for the same franchise. In 2022, she relocated to Vienna and assumed the role of business unit director for respiratory, immunology, and vaccines, with responsibility for strategy, performance, and commercial leadership. Fellner joined AOP Health in 2025, where she oversees the company's global therapeutic areas. In this role, she leads lifecycle strategy development and drives international brand integration across functions and markets to accelerate sustainable portfolio growth. About AOP Health AOP Health is a global enterprise group with roots in Austria, where the headquarters of AOP Orphan Pharmaceuticals GmbH ("AOP Health") is located. Since 1996, the AOP Health Group has been dedicated to developing innovative solutions to address unmet medical needs, particularly in the fields of rare diseases and intensive care medicine. The group has established itself internationally as a pioneer in integrated therapy solutions and operates worldwide through subsidiaries, representations, and a strong network of partners. With the claim "Needs. Science. Trust." the AOP Health Group emphasizes its commitment to research and development, as well as the importance of building relationships with physicians and patient advocacy groups to ensure that the needs of these stakeholders are reflected in all aspects of the company's actions.

In this episode, Dustin chats with Michelle Craig, Director of Marketing at AppsAnywhere, about how institutions can better support today's digitally fluent, mobile-first students. They explore the critical need for flexibility in how students access learning tools and why digital equity isn't just a nice-to-have — it's a must. From device agnosticism to smarter infrastructure investments, this conversation gives IT leaders and enrollment pros alike actionable ways to align tech strategy with student realities.Guest Name: Michelle Craig - Director of Marketing at AppsAnywhereGuest Social: LinkedInGuest Bio: Michelle Craig is the Senior Director of Marketing and Commercial Operations at AppsAnywhere. With a focus on innovative go-to-market strategies and cross-functional leadership, she brings a results-oriented approach to connecting AppsAnywhere's solutions which help universities simplify software access for over three million students across 300 institutions worldwide. She brings two decades of EdTech experience from senior roles at Blackboard, QS Unisolution, JobTeaser, and Solutionpath. - - - -Connect With Our Host:Dustin Ramsdellhttps://www.linkedin.com/in/dustinramsdell/About The Enrollify Podcast Network:The Higher Ed Geek is a part of the Enrollify Podcast Network. If you like this podcast, chances are you'll like other Enrollify shows too!Enrollify is made possible by Element451 — The AI Workforce Platform for Higher Ed. Learn more at element451.com. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Kate Voyten is a seasoned business leader with over 20 years of experience revitalizing small brands and stagnant businesses. She started her career at Procter & Gamble, working first in operations and eventually moving into brand management, where she ran businesses across the U.S., Europe, and Asia. Her consumer-centric approach to innovation and commercial strategies, combined with her operational expertise, has helped transform businesses across consumer goods, automotive, and healthcare categories. Some of her favorite challenges include relaunching the iconic $500 million Herbal Essences brand and returning it to profitable growth, spearheading the digital transformation and omnichannel strategy for the Hertz loyalty program, and building the OneTouch diabetes business in retail and e-commerce. Today, Kate is the Chief Commercial Officer at Cadence OTC, where she is leading the effort to bring the next generation of oral contraceptives over the counter—expanding access to safe, affordable birth control for millions of women across the U.S. Kate is passionate about developing people and building partnerships that deliver meaningful business transformations. She earned both her BS and MS from Carnegie Mellon University. In This Conversation We Discuss:[00:00] Intro[01:24] Meeting customers' urgent health needs[08:03] Focusing on signals that show real intent[11:33] Callouts[11:42] Turning urgent needs into long-term loyalty[13:32] Navigating advertising in regulated industries[16:04] Investing upfront to avoid costly rework[19:02] Sponsor: Electric Eye[20:10] Leveraging AI to uncover customer insights[24:22] Providing clarity through educated communicationResources:Subscribe to Honest Ecommerce on YoutubeAffordable emergency contraception, convenient access cadenceotc.com/Follow Kate Voyten LinkedIn linkedin.com/in/katherine-voytenSchedule an intro call with one of our experts electriceye.io/connectIf you're enjoying the show, we'd love it if you left Honest Ecommerce a review on Apple Podcasts. It makes a huge impact on the success of the podcast, and we love reading every one of your reviews!

Transmission is getting a glow up and we want to hear from you what we can improve. Help us by filling in this short survey. https://form.typeform.com/to/kCdj85iK?typeform-source=www.linkedin.comCan energy-only market design deliver both reliability and affordability as electricity grids face unprecedented transformation?In this episode, Alex speaks with Keith Collins, Vice President of Commercial Operations at ERCOT, about managing the unprecedented challenges facing Texas's electricity grid. As data centers and AI facilities flood into the state, ERCOT must balance explosive demand growth with affordability and reliability all within an energy-only market structure that's unique among major US grid operators.Chapters:00:00 ERCOT's role in Texas grid management01:09 Electricity market design and efficiency02:28 Winter Storm Uri and resource adequacy04:40 Texas data center boom explained06:39 Energy-only markets and price signals08:18 Grid resource adequacy challenges12:28 Dispatchable reliability reserve service ECRS18:45 Real-time energy and ancillary services22:15 765kV transmission expansion in Texas26:30 Residential demand response and virtual power plants31:45 Comparing ERCOT to other US markets36:27 Future grid technologies and storage growth40:05 Distributed battery systems and grid integration41:05 ERCOT market design frameworkYou can watch or listen to new episodes every Tuesday and Thursday.Transmission is a Modo Energy production. Your host is Ed Porter, our VP of Insights.Modo Energy helps the owners, operators, builders, and financiers of battery energy storage understand the market — and make the most out of their assets. Want all the latest power market news? Sign up for our free Weekly Dispatch newsletter: https://bit.ly/TheWeeklyDispatch

Transmission is getting a glow up and we want to hear from you what we can improve. Help us by filling in this short survey. https://form.typeform.com/to/kCdj85iK?typeform-source=www.linkedin.comCan energy-only market design deliver both reliability and affordability as electricity grids face unprecedented transformation?In this episode, Alex speaks with Keith Collins, Vice President of Commercial Operations at ERCOT, about managing the unprecedented challenges facing Texas's electricity grid. As data centers and AI facilities flood into the state, ERCOT must balance explosive demand growth with affordability and reliability all within an energy-only market structure that's unique among major US grid operators.Chapters:00:00 ERCOT's role in Texas grid management01:09 Electricity market design and efficiency02:28 Winter Storm Uri and resource adequacy04:40 Texas data center boom explained06:39 Energy-only markets and price signals08:18 Grid resource adequacy challenges12:28 Dispatchable reliability reserve service ECRS18:45 Real-time energy and ancillary services22:15 765kV transmission expansion in Texas26:30 Residential demand response and virtual power plants31:45 Comparing ERCOT to other US markets36:27 Future grid technologies and storage growth40:05 Distributed battery systems and grid integration41:05 ERCOT market design frameworkYou can watch or listen to new episodes every Tuesday and Thursday.Transmission is a Modo Energy production. Your host is Ed Porter, our VP of Insights.Modo Energy helps the owners, operators, builders, and financiers of battery energy storage understand the market — and make the most out of their assets. Want all the latest power market news? Sign up for our free Weekly Dispatch newsletter: https://bit.ly/TheWeeklyDispatch

Why do forecasts look great right up until they don't? If your Rev Ops strategy stops at the point of sale, you aren't managing revenue—you're managing blind spots. Courtney Baker, David DeWolf, and Mohan Rao kick off a new series on Commercial Operations. They explain why the "lone wolf" days of account management are over and how AI turns "digital exhaust" into objective data—bringing the same discipline to client retention that we apply to winning new deals. Pete Buer sits down with Dr. Vasant Dhar, author of Thinking With Machines. Dr. Dhar explains "Dhar's Conjecture" and how gaining a "Roger Federer edge"—just a 54% win rate—can compound into an unbeatable competitive advantage. Plus, the experimentation phase is officially over. Pete breaks down new data showing that 98% of board members have made measuring AI ROI their top priority for 2026. Register for our upcoming webinar on implementing RevOps throughout the client lifecycle: Knownwell.com/revops Watch the full episode on YouTube: https://www.youtube.com/watch?v=Sy0ISl6RPa4

Laura DePasquale is the Senior Vice President of Commercial Operations for Artisanal Wine at Southern Glazer's Wine & Spirits and a Master Sommelier whose impact reaches far beyond the glass. Laura brings heart, intellect, and vision to everything she does - from championing people, elevating wine educationl, and driving meaningful growth for winemakers

This is the time of year when we share with you some excerpts from the most recent University of South Carolina Darla Moore School of Business Economic Outlook Conference. Today's excerpt comes from Cody Thacker, Vice President of Commercial Operations, Scout Motors.

The NMIA, inaugurated by Prime Minister Narendra Modi on 8 October, is expected to serve passengers from Navi Mumbai along with neighbouring areas— Thane, Raigad, Pune and parts of the Konkan region. It will be operated by the NMIAL which is also an Adani Subsidiary. Watch Kasturi Walimbe explain the details of operations in #ThePrintVideo

Space lasers again! Odysseus Space from Luxembourg focuses on providing optical communications solutions between Space and Earth as a service. If you seem to notice that is not the first episode on optical communications, you're right – I think this will be a potentially very big theme going forward. Our guest this week is Odysseus' CEO & Co-Founder Jordan Vannitsen. Enjoy!

Text us your questions and thoughts!Sometimes the fastest way to grow your influence isn't chasing a bigger title,  it's expanding your understanding of how the business actually works.In this episode, we sit down with Emily Nguema, Senior Manager, Commercial Operations at Relay Technologies, to unpack her non-linear journey from studying languages and doing humanitarian work in Ecuador to partner success, edtech, and ultimately a far-reaching role in commercial operations. Through every pivot, one thread stays constant: value - how to define it, measure it, and translate it into stories executives can do something with.We explore:What it really looks like to shift from senior CSM to commercial opsHow embracing ambiguity becomes a competitive advantage in fast-moving orgsEmily's personal operating system (weekly roadmaps, calendar-bound priorities, and celebrating small wins like it's a sport)Humility as the hidden accelerator for influence and leadershipCareer decisions that prioritize learning, exposure, and meaningful impact over titlesYou'll also hear a fresh take on consultative customer success, executive-ready storytelling, and the mindset shift that helps CS professionals influence at higher levels (long before they have a formal leadership title).If you're eyeing a move into operations, or simply want your customer success strategy to resonate in the boardroom, this episode will give you both the frameworks and the courage to go for it.And if this conversation sparked something for you, share it with a colleague or teammate who needs the boost today.

Shoot us a Text.Episode #1213: Today we're talking Scout's aggressive service-first launch strategy, Carvana's stunning rise past Detroit's giants as it joins the S&P 500, and Waymo's shift from polite AV to confidently assertive city driver.Show Notes with links:Scout Motors is doubling down on a factory-run service network as it preps for a 2027 U.S. launch, betting that premium, reliable service will become a differentiator in the direct-to-consumer EV space.Scout will open 25 brand-owned rooftops at launch, both “Studios,” where customers shop and interact with a sales adviser, and “Workshops,” where service is performed. 57 rooftops are planned in Year 2.The brand plans 15% more annual service labor capacity than projected need to stay ahead of demand and reduce wait times.Scout aims to staff 1,400 service bays with roughly 900 technicians within five years, backed by VW Group resources but operating independently.“The way we describe our retail operations is a digital-first experience built on a service-first infrastructure.” — Cody Thacker, VP Commercial Operations, ScoutCarvana's comeback is officially Wall Street-certified as the online used-car disruptor joins the S&P 500, marking a stunning rebound from near-bankruptcy to an $87B valuation that now eclipses Ford and GM.Shares have surged more than 8,000% since 2022 and nearly doubled in 2025 as demand rebounded and cost discipline kicked in.Carvana now trades at 57× forward earnings, massively outpacing Detroit's single-digit multiples.The company sold a record 155,941 units in Q3, driving 55% revenue growth and fueling analyst confidence in potential volume leadership over CarMax by 2026.Index inclusion on Dec. 22 is expected to trigger significant buying from funds tracking the S&P.Waymo's once overly-courteous robotaxis are getting a software personality shift in San Francisco—assertive, human-like driving that's raising eyebrows, improving flow, and occasionally bending rules.Riders report more aggressive lane changes, quicker merges, and tighter gaps—closer to how real-world urban drivers operate.The shift follows complaints that overly passive AVs caused congestion, got stuck behind obstacles, and struggled downtown.Recent incidents include an illegal U-turn, a lane-change with no signal, and even a tragic neighborhood cat strike—fueling debate over “too human” behavior.Waymo says more assertiveness is required to scale in busy cities, with updates teaching AVs to make “common-sense decisions” when laws conflict.Thank you to today's sponsor, Mia. Capture more revenue, protect CSI, and never miss a call or connection again with 24/7 phone coverage and texting (SMS) follow-up for sales, service, and reception. Learn more at https://www.mia.inc/Join Paul J Daly and Kyle Mountsier every morning for the Automotive State of the Union podcast as they connect the dots across car dealerships, retail trends, emerging tech like AI, and cultural shifts—bringing clarity, speed, and people-first insight to automotive leaders navigating a rapidly changing industry.Get the Daily Push Back email at https://www.asotu.com/ JOIN the conversation on LinkedIn at: https://www.linkedin.com/company/asotu/

Marc Esteve, Executive Director of Commercial Operations at BEEAH, explains the exciting plans for BEEAH to pursue the service industry, providing an added sustainable touch to household services that the Sharjah community will cherish alongside innovative and futuristic technologies. Listen to #Pulse95Radio in the UAE by tuning in on your radio (95.00 FM) or online on our website: www.pulse95radio.com ************************ Follow us on Social. www.facebook.com/pulse95radio www.twitter.com/pulse95radio

Tune in for a conversation with David Dorman, Director of Commercial Operations at APR Energy. David shares how mobile gas-turbine solutions deliver hundreds of megawatts “behind the meter,” enabling data centers and municipalities to bridge grid delays, accelerate AI and cloud expansion, and meet surging energy demands. From disaster recovery projects in Puerto Rico to modular power strategies for hyperscale growth, this conversation reveals how converging energy and digital networks power the future of connectivity.

The Dell Technologies Forum took place today at the RDS in Dublin with Peter O'Mahony, former Ireland rugby captain and Grand Slam winner, Lynne Cantwell, most capped Irish women's rugby player and Head of Women's Strategy at the IRFU, David Humphreys, former Ireland international and Performance Director at the IRFU headlining the event which showcased how AI can help organisations drive peak performance, increase productivity and spark innovation. The Forum brought together approximately 600 of business and IT leaders to explore the latest developments in AI-powered transformation, the next generation of AI PCs, modern data centres and multicloud strategies. Conversations centred on how these advances can help strengthen competitiveness and unlock new growth opportunities. Across the keynote, solutions expo, curated breakout sessions, insightful panels and more, decision makers heard from a range of exciting experts and speakers on the innovative solutions that can empower them to transform at speed and scale up their success. This comes as Dell's Innovation Catalyst Study 2025 revealed that while 76% of Irish organisations view AI as a strategic driver of business growth, almost half (46%) are struggling to keep pace with rapid technological change and concerns around security, expertise and compliance. Peter O'Mahony took to the stage to share lessons from elite sport on building a high-performance culture on and off the pitch, while Lynne Cantwell and David Humphreys discussed how teamwork, leadership and innovation can help organisations thrive in an era of technological transformation. Other speakers included Jason Ward, EMEA North Vice-President and Managing Director of Dell Technologies Ireland; Alyssa Boyle, Head of Commercial Operations at Studio Ulster; and Gemma Leo, Head of Business Support & Projects at the Crann Centre. Speaking at the Dell Technologies Forum, Mark Hopkins, General Manager of Dell Technologies Ireland, said: "AI is no longer a question of "if" - it's a question of how to make it work better, faster, and more securely to provide the right outcomes for your business. Leaders across Ireland are now looking to scale AI responsibly, modernise infrastructure and prepare their workforce for what's next. Through this year's Dell Technologies Forum, we're bringing together the technologies, insights, and collaborations that help businesses turn ambition into action. Whether it's scaling GenAI, modernising infrastructure, or empowering the workforce with AI-enabled devices, the Forum is where organisations see what's possible - and how to make it real. "The insights of Irish rugby legends, alongside leading voices from the technology and business sectors, highlighted how teams can achieve peak performance - whether on the field or in the boardroom. At Dell Technologies Ireland, we are committed to helping organisations across the country harness AI and emerging technologies to innovate with confidence and turn potential into tangible results." To find out more about the Dell Technologies Forum, click here. More about Irish Tech News Irish Tech News are Ireland's No. 1 Online Tech Publication and often Ireland's No.1 Tech Podcast too. You can find hundreds of fantastic previous episodes and subscribe using whatever platform you like via our Anchor.fm page here: https://anchor.fm/irish-tech-news If you'd like to be featured in an upcoming Podcast email us at Simon@IrishTechNews.ie now to discuss. Irish Tech News have a range of services available to help promote your business. Why not drop us a line at Info@IrishTechNews.ie now to find out more about how we can help you reach our audience. You can also find and follow us on Twitter, LinkedIn, Facebook, Instagram, TikTok and Snapchat.

In an engaging episode of the Female Auto Connect Podcast, we were joined by Åsa Borg from Polestar's global Group Management. Our conversation delved into the recent challenges facing the electric vehicle (EV) and broader automotive industry. Åsa provided valuable insights into how Polestar is navigating these market dynamics, outlining the strategies the company is implementing to stay ahead in a competitive landscape. She also shared a candid look at her experience in top management, offering a unique perspective on what it takes to lead at an innovative, up-and-coming automotive brand. Hosted on Acast. See acast.com/privacy for more information.

In an engaging episode of the Female Auto Connect Podcast, we were joined by Åsa Borg from Polestar's global Group Management. Our conversation delved into the recent challenges facing the electric vehicle (EV) and broader automotive industry. Åsa provided valuable insights into how Polestar is navigating these market dynamics, outlining the strategies the company is implementing to stay ahead in a competitive landscape. She also shared a candid look at her experience in top management, offering a unique perspective on what it takes to lead at an innovative, up-and-coming automotive brand.

On this episode of The Vitamin Professor Podcast, Professor Gene Bruno talks to Rick Handel of VITAQUEST. Rick Handel is a 50-year veteran of the nutraceutical industry, with a strong background in formulation, R&D and GMP manufacturing of dietary supplements. Rick is celebrating 30 years with industry-leading supplement manufacturer Vitaquest International, where he currently serves as Senior Vice President of Commercial Operations. In that capacity, Rick is responsible for driving sales and innovation by identifying and developing new strategies, business opportunities, science-backed ingredients and novel delivery technologies. Rick holds eight patents, is a published author, and has presented his scientific papers and studies at conferences around the world.This podcast is brought to you in partnership with VRM Media and Nutraland USA, Inc.For more information about our host and guest, please see the below information.https://vitaquest.com/https://nutralandusa.com/https://www.linkedin.com/in/rickhandel/https://www.linkedin.com/in/dr-gene-bruno-dbm-ms-rh-ahg-2ab0508/www.vrmmedia.com@hnvirtual, #hnvirtual, #rickhandel, #vitaquest, #genebruno, #thevitaminprofessorFind our podcast on your favorite platform:podcasts.apple.com/us/podcast/the-vitamin-professor-podcast/id1746137375youtube.com/channel/UCxeQ-IuqCRmq0YLc7jQNMKAmusic.amazon.com/podcasts/a8a96593-b93c-48cf-9fe9-2891c4035dad/the-vitamin-professor-podcastiheart.com/podcast/269-the-vitamin-professor-podc-175888136/

What do rocket science and commercial operations have in common? More than you think!In this episode, Mir Zaman, Vice President of Commercial Operations at Spectrum Brands, shares what he brought with him from the aeropsace industry to Amazon—and now to one of the most diverse brand portfolios in consumer goods. From challenging legacy systems to scaling creative content across categories like pet care, home improvement, and garden, Mir offers a clear blueprint for modern growth.We also dive into:Lessons from nearly a decade at Amazon (and how to keep that entrepreneurial spirit alive in big companies)Building a center of excellence that still feels like part of the teamThe power of two-way door decisions—and knowing when to test, pivot, or go all-inWhy AI will only work in CPG if it's tailored to different stages of maturityConnect with Mir on LinkedInFollow Beyond the Shelf on LinkedInLearn More about It'sRapidGet the It'sRapid Creative Automation PlaybookTake It'sRapid's Creative Workflow Automation with AI surveyEmail us at sales@itsrapid.io to find out how to get your free AI Image AuditTheme music: "Happy" by Mixaud - https://mixaund.bandcamp.comProducer: Jake Musiker

In 2025, we're embarking on a MedDevice Training Journey: From clinical trials to standard of care. Join us all year long as we explore training at each stage of the product life cycle.Need help developing your clinical trial training strategies? Contact us at training@cumbyconsulting.com.Related Resources:Tony Recupero is President, Commercial Operations of SI-BONE. Tony leads SI-BONE's commercial operations, including sales, market access, reimbursement, professional education and international. He is a proven commercial leader, responsible for the company's go to market strategy that has led to exponential revenue growth. Prior to SI-BONE, Tony was formerly the President of Catalyst Performance Advisors where he advised several medical device companies on commercial strategy. Tony was previously President and CEO of Baxano, Inc. Tony was also the Vice President of Sales for Kyphon from startup in 1999 through the end of 2004. Kyphon was acquired by Medtronic for $4.2 billion dollars. Early in his career, Tony progressed to senior sales management roles at United States Surgical Corporation and Sulzer Spine-Tech, Inc. Tony earned a B.A. in Communications from State University of New York at Albany and attended The General Management program at Harvard Business School.Subscribe to our newsletter to hear more about the journey from clinical trials to standard of care! Click here to subscribe! Connect with us on LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Tony Recupero⁠⁠⁠⁠Cumby Consulting⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Rachel Medeiros⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Liz Cumby⁠⁠⁠⁠⁠About Cumby Consulting:Cumby Consulting's team of professionals deliver innovative MedTech training services for physicians, sales representatives, teaching faculty, key opinion leaders and clinical development teams. Whether you need a complete training system developed to deliver revenue sooner or a discrete training program for a specific meeting, Cumby Consulting will deliver highly strategic, efficient programs with uncompromising standards of quality.

Synopsis: When an introverted engineer becomes the President & CEO of REGENXBIO, transformation follows. Curran Simpson joins host Rahul Chaturvedi to unpack his unlikely journey from biotech operations to the C-suite—and how that hands-on experience is reshaping gene therapy's future. They dive into the evolution of REGENXBIO's pipeline, tackling ultra-rare diseases like MPS II, ambitious plans for Duchenne Muscular Dystrophy, and commercial partnerships with giants like AbbVie. Curran offers hard-earned leadership lessons, honest reflections on scaling science, and insights into how one-time gene therapies could revolutionize treatment in both rare and common diseases. From clinical nuance to strategic boldness, this is a masterclass in biotech leadership, platform focus, and staying patient-first—no matter how complex the science or market. Biography: Curran M. Simpson is the President and Chief Executive Officer and member of the Board of Directors at REGENXBIO. Mr. Simpson previously served as the Company's Chief Operating Officer. In that role, he led key business functions including Research & Clinical Development, Corporate Strategy, Manufacturing & Quality, Regulatory, and Commercial Operations. Mr. Simpson joined REGENXBIO in 2015 with extensive leadership experience across biopharmaceutical operations and served as the Company's Chief Technology and Operations Officer before becoming COO. Prior to joining REGENXBIO, he was the Regional Supply Chain Head for North America and Interim Chief Operating Officer at GlaxoSmithKline (GSK). Mr. Simpson earlier served as interim CEO of Human Genome Sciences (HGS), where he led the integration of HGS into GSK, and as Senior Vice President of Operations and Vice President of Manufacturing Operations at HGS. Prior to HGS, Mr. Simpson was Director of Manufacturing Sciences at Biogen. Earlier in his career, Mr. Simpson served in an overseas assignment at Novo-Nordisk Biochem in Denmark and in various senior development and engineer roles at Genentech, working on Herceptin and Avastin, among other roles. Mr. Simpson has an M.S. in surface and colloid science from Clarkson University and a B.S. in chemistry from the Clarkson College of Technology.

In this episode we talk with Piete Casius, President & CEO of Friendship Industries. Living in the Shenandoah Valley since 2008, he shares the journey that brought him to Virginia and eventually to his leadership role. Starting as Director of Commercial Operations at Friendship Industries in 2016, Piete reflects on how working at a nonprofit has shaped him personally—and the meaningful impact the organization has on the community.

Have you ever wondered what it's like to look after the elephants at Dublin Zoo? From training them to giving them pedicures, elephants can be very high maintenance. Christina Murphy is the Elephant Team Leader at Dublin Zoo and she told Pat what that's like. Also joining us is Jenny Dunne, Head of Commercial Operations who is going to talk to us about all the upcoming events happening here at Dublin Zoo from the Zoorassic Trail Takeover to their first ever Run for Wildlife.The show today was live from Dublin Zoo as part of Newstalk Summer Tour 2025 with thanks to ESB's 1600 EV chargers across Ireland giving you the freedom to go further.

How do you market sensitive women's health products when advertising platforms won't let you talk about them? In this episode, Stewart Gandolf and Debbie Donovan, Head of Commercial Operations at Materna Medical, explore the unique challenges of marketing products that address women's health issues, such as vaginal muscle tightness, pelvic organ prolapse, and painful sex.

This week I had the pleasure of speaking with Lioba Oerter, Director of Expert Services, 3E Expert Service Processing Centre (ESPC), and Karin F. Baron, Director of Hazard Communication and International Registration Strategy at B&C and our consulting affiliate, The Acta Group, about the significant changes to product classification, labeling, and packaging (CLP) in the European Union (EU). Lioba and I shared a podium recently and found we also have a shared belief that these forthcoming CLP changes will have a profound commercial impact on product classification, labeling, and packaging globally and that with everything going on in the world these days, this impact may be a bit underappreciated. Karin and I spoke about these matters last year, and I welcomed an opportunity to consider them again with Karin and Lioba in light of the new CLP developments as of December 2024. Karin, Lioba, and I discuss the CLP changes, including those recently made, why they came to be, what they mean for commercial operations, and conclude with some tips on staying ahead of this coming storm. ALL MATERIALS IN THIS PODCAST ARE PROVIDED SOLELY FOR INFORMATIONAL  AND ENTERTAINMENT PURPOSES. THE MATERIALS ARE NOT INTENDED TO CONSTITUTE LEGAL ADVICE OR THE PROVISION OF LEGAL SERVICES. ALL LEGAL QUESTIONS SHOULD BE ANSWERED DIRECTLY BY A LICENSED ATTORNEY PRACTICING IN THE APPLICABLE AREA OF LAW. ©2025 Bergeson & Campbell, P.C.  All Rights Reserved

2025 7th Annual Capital Link Singapore Maritime Forum | Charterer’s Perspective The Forum sought to underscore Singapore's pivotal role as a gateway to Asia and a key player in the global shipping markets. It explored key developments and emerging trends in energy, commodities, and various shipping sectors, alongside insights into the global financial and capital markets. The agenda also addressed critical topics such as global trade, regulatory advancements in shipping, digitalization, technological innovation, and energy transition. Moderator: Ms. Evie Jenie, Legal Director – Hill Dickinson Panelists: • Mr. Peter Lye, Executive Head of Marketing – Shipping & Safety – Anglo American • Ms. Sarah Greenough, Head of Maritime Enterprise – BHP • Mr. Andrew Hoare, Head of Green Shipping – Fortescue • Mr. Scott Bergeron, Managing Director, Fleet – Oldendorff Carriers • Ms. Laure Baratgin, Head of Commercial Operations – Rio Tinto • Mr. Rodrigo Bermelho, Director, Global Head of Shipping and Distribution – Vale The Forum was held in partnership with ABS, and in cooperation with Columbia Shipmanagement and Singhai Marine Services, and in conjunction with the 2025 Singapore Maritime Week. Tuesday, March 25, 2025 The Westin Singapore More Info: https://shorturl.at/mQL0L #ShippingIndustry #MarineIndustry #ShippingLeadership #MaritimeExperts #Forums #Capitallink #SMW2025

Today we are breaking down Watsco, the market leader in HVAC distribution with a unique value proposition. If you've ever had an air conditioning issue, there's a decent chance it was a Watsco distributor on the other side of that phone call.    My guests today are Lucy Adams, Investment Director at Caledonia Investments, and Alan Murran, Co-Head of Public Companies at Caledonia Investments. Lucy and Alan help track the history of Watsco like the initial pivot from manufacturer to distributor and how Watsco formed relationships with the major OEMs like Carrier. We also dissect their reputation for a strong culture, with what has to be one of the most unique employee compensation plans in effect. Please enjoy this breakdown of Watsco. Subscribe to Colossus Review For the full show notes, transcript, and links to the best content to learn more, check out the episode page here. ----- Business Breakdowns is a property of Colossus, LLC. For more episodes of Business Breakdowns, visit joincolossus.com/episodes. Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com). Show Notes (00:00:00) Welcome to Business Breakdowns (00:03:34) Watsco's Role in HVAC Distribution (00:04:40) Watsco's Business Model and Services (00:06:42) Real-World Example of Watsco's Impact (00:09:28) Market Position and Competition (00:12:55) Historical Evolution of Watsco (00:15:52) Exclusivity Agreements in HVAC Industry (00:18:05) Residential vs. Commercial Operations (00:21:04) Growth Strategies and M&A Philosophy (00:26:45) Carrier Joint Venture and Future Opportunities (00:29:40) Watsco's Multi-Brand Acquisition Strategy (00:31:34) Gross and Operating Margin Expansion (00:33:24) Pricing Strategies and Market Dynamics (00:35:16) Recurring Revenue and Business Model (00:37:36) Cash Flow Management and Capital Allocation (00:40:52) Technology Adoption and Digital Transformation (00:45:50) Incentive Programs and Ownership Culture (00:50:45) Risks and Competitive Landscape (00:55:02) Lessons from Watsco

Industrial Talk is onsite at Accruent Insights and talking to Meelad Nikpourian, Vice President, Commercial Software and Strategy at Accruent about "Innovative suite of solution focused on success". Scott MacKenzie and Meelad discuss the Accruent Insights conference in San Antonio, highlighting Accruent's global customer base and recent acquisitions, including a full SaaS EDMS product from Australia. Meelad, VP of Commercial Operations, explains Accruent's strategy to simplify the buying process and integrate solutions, emphasizing the importance of customer insights. They discuss the integration of Accruent's EDMS with Service Channel, enhancing retail maintenance and predicting asset degradation. Meelad notes the significant financial impact of food spoilage and the potential for insurance integration. Looking ahead, Meelad sees Accruent becoming more global and innovative, with a focus on customer-driven solutions. Action Items [ ] Explore the potential insurance benefits for customers by integrating Accruent's asset monitoring data. [ ] Follow up on expanding Accruent's global reach and customer use cases across different markets. [ ] Connect with Melan on LinkedIn to discuss further opportunities. Outline Accruent Insights Conference Overview Scott MacKenzie introduces the podcast and highlights the importance of celebrating industry professionals. Scott mentions the current event at Accruent Insights in San Antonio, Texas, emphasizing the problem-solving atmosphere. Scott and Meelad discuss the success of the conference and the importance of customer insights in driving solutions. Meelad mentions the new leadership under Richard Lurick and the global reach of Accruent's customer base. Introduction of Speaker 2 and Role Meelad introduces himself as the Vice President of Commercial Operations and Strategy at Accruent. He explains his role in working closely with global go-to-market teams, marketing, sales, and product leaders. Meelad emphasizes the importance of providing a seamless experience for both prospects and customers throughout the buying cycle. He describes the conversion process from lead capture to nurturing and handing over to account executives. Challenges in the Buying Process Scott and Meelad discuss the increasing complexity of the buying process with more stakeholders involved. Meelad highlights Accruent's efforts to reduce complexity by making the buying process easier and integrating solutions. They talk about the importance of providing combined packages that add more value to customers. Meelad clarifies that Accruent still caters to single-point solutions and the importance of integrations with external products. Integration and Customization of Solutions Meelad explains the integration of Accruent's solutions with leading CMS and EDMS products. He emphasizes the importance of providing a holistic solution for customers, regardless of their portfolio. Scott and Meelad discuss the potential for adding value by integrating existing products with new solutions. Meelad mentions the bi-directional integration with Service Channel, a leading CMS for the retail space. Retail Use Case and AI Capabilities Meelad provides a detailed use case for a grocery store using Accruent's solutions to monitor and predict

Peter Vaughan Schmidt, CEO, Torc joined Grayson Brulte on The Road to Autonomy podcast to discuss how Torc is preparing to launch commercial operations in Texas.Torc's strategic relocation from Albuquerque to Fort Worth, Texas was a move that aligned with changing market dynamics. The regulatory environment combined with a growing demand for freight movement, makes Texas the ideal market to launch s commercial autonomous trucking operations.Looking ahead to 2027, Torc plans to launch commercial autonomous trucking operations in Texas. When the service is launched, customers will purchase autonomous-ready Cascadias from Freightliner, own the asset and subscribe to Torc's virtual driver service.Recorded on Tuesday, January 14, 2025Episode Chapters0:00 Torc Moves from Albuquerque to Texas4:37 Autonomous-Ready Cascadias8:57 Preparing for Driver-Out Operations11:01 Torc's Perception System12:22 From a Robotics Stack to an AI Stack15:26 Autonomous Truck Policy17:08 AI's Is Accelerating Torc's Commercial Launch20:32 Scaling Commercial Operations22:39 Buying an Autonomous Truck Powered by Torc24:24 Torc Business Model30:07 Autonomous Truck Maintenance34:09 Capital Allocation Strategy37:21 Outside Capital39:44 Additional OEMs41:05 Waymo43:29 Autonomous Trucking Market45:17 Torc Outlook--------About The Road to AutonomyThe Road to Autonomy® is a leading source of data, insight and commentary on autonomous vehicles/trucks and the emerging autonomy economy™.Sign up for This Week in The Autonomy Economy newsletter: https://www.roadtoautonomy.com/autonomy-economy/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Kathy Fraley retired as the Service Center Director for the Travelers Select Service Center located in Spokane, Washington and Colorado Springs, Colorado. Her teams were responsible for providing direct service to insureds and agents in all states. Kathy has spent more than 30 years in the agents and carrier ranks. Her career started in the underwriting side at a carrier and after 4 years moved to the agency side. Prior to joining Travelers, Kathy retired after 28 years as a partner/owner from Propel Insurance where she held the position of Vice President of Marketing and Commercial Operations located in the Pacific Northwest. Kathy developed a passion for the industry and feels it is important to give back to the industry by teaching. She has been a teacher in the Junior Achievement program and enjoyed working with students as they learned about community involvement. Kathy earned her CIC designation in 1987 and has previously served on the CISR Board of Governors. She also acts as an instructor and Education Consultant for various programs with the Risk & Insurance Education Alliance. Focusing exclusively on risk management and insurance professional development, the Risk & Insurance Education Alliance provides a practical advantage at every career stage, positioning our participants and their clients for confidence and success.

Tom Lyons of The Currency discusses the fall-out for Conor McGregor since he lost the civil rape case taken against him by Nikita Hand.

Daniel Goff, Director of External Affairs, Kodiak joined Grayson Brulte on The Road to Autonomy podcast to discuss what the autonomous trucking industry needs from Washington, D.C. in order to scale commercial operations. Autonomous trucking regulations are often misunderstood. Contrary to popular belief, the legal and policy frameworks for deploying autonomous trucks on U.S. roadways are more advanced than many assume. The necessary regulatory elements are already in place, allowing for immediate deployment and scaling of autonomous trucks. While the necessary regulatory elements are already in place, what does the autonomous trucking industry need from Washington, D.C. to have regularity certainty? Tune in to find out. Episode Chapters0:00 Current State of Autonomous Trucking Regulations 3:58 Investor Thoughts on Autonomous Trucking Regulations 6:11 Public's Perspective on Autonomous Trucks and Vehicles 10:17 Human Trafficking 13:02 Law Enforcement Interaction 20:22 Federal Autonomous Vehicle Framework30:59 National Security Issues 33:41 Tech and Labor Tensions 40:15 Autonomous Trucks in California 44:00 2025 OutlookRecorded on Monday, November 25, 2024--------About The Road to AutonomyThe Road to Autonomy® is a leading source of data, insight and commentary on autonomous vehicles/trucks and the emerging autonomy economy™.Sign up for This Week in The Autonomy Economy newsletter: https://www.roadtoautonomy.com/autonomy-economy/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Grace Hyde is the Director of Commercial Operations for District Cannabis, a thriving cultivator providing premium flower to the Washington D.C. and Maryland markets. Grace oversees innovation across the company. In addition, she is responsible for government relations in Washington, D.C., and operational oversight of the D.C. cultivation facility. She previously held management positions in wholesale and retail cannabis operations in D.C. and Rhode Island. She discusses topics such as the regulatory and market challenges facing retail cannabis operations in DC and Maryland and exciting developments at District Cannabis, a trusted brand of high-quality cannabis products in DC and Maryland.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

In this episode of Life Science Success, we welcome Ani Sinha, the Vice President of Commercial Operations at Shionogi Inc. Ani brings nearly 15 years of deep commercial expertise in the pharmaceutical and biotech industries. She shares her inspiring journey from studying microbiology and biochemistry at Yale and Columbia to holding strategic leadership roles at companies like Pfizer, Bayer, and Celgene. We delve into her current role at Shionogi, exploring how she leads functions like Analytics and Insights, Market Research, and Field Operations. Ani discusses the innovative projects she's excited about and how they're contributing to Shionogi's mission. She also shares the greatest piece of leadership advice she's ever received and opens up about what inspires, concerns, and excites her in the world of life sciences. Tune in to gain valuable career insights and explore the dynamic future of pharmaceutical advancements.   00:00 Introduction to Life Science Success Podcast 00:42 Sponsor Message: D3 Digital Media Marketing 01:25 Interview with Ani Sinha Begins 02:08 Ani Sinha's Career Journey 05:18 Transition from Lab to Consulting 07:58 Skills Gained from Management Consulting 11:25 Joining Shinogi and Role in Commercial Operations 20:13 Future of Commercial Operations 22:21 Building a Team: The Land of Misfit Toys 23:02 Navigating Different Companies and Roles 24:05 The Evolving Role of Analytics and Insights 25:41 Challenges in Market Research and Operations 29:32 Addressing Trends in Biotech and Pharma 32:13 Greatest Leadership Advice Received 34:44 Inspiration and Concerns in the Pharma Industry 40:52 Final Thoughts and Farewell

In this episode, we have a conversation with Cam McKenzie, VP of Commercial Operations at PacBio and a leader in the genomics and life sciences industry. McKenzie discusses the innovative transformation of PacBio's commercial operations under the guidance of CEO Christian Henry, focusing on overcoming challenges like siloed operations and minimal infrastructure through strategic Salesforce integration and omnichannel strategies.  We also delve into the potential for innovation at the intersection of technology and human collaboration. McKenzie emphasizes the importance of fostering a culture of continuous learning and adaptability to stay ahead in the rapidly evolving field of genomics. Show Highlights: Strategic transformation of PacBio's commercial operations, focusing on Salesforce integration and omnichannel strategies. Challenges faced by PacBio and the innovative solutions implemented. Insights into the complexities of PacBio's business model. The impact of technology in streamlining sales processes and improving customer interactions. Reflection on the importance of diverse perspectives and optimism for future innovation at the intersection of technology and human collaboration. Follow and Review: We'd love for you to follow us if you haven't yet. Click that purple '+' in the top right corner of your Apple Podcasts app. We'd love it even more if you could drop a review or 5-star rating over on Apple Podcasts. Simply select “Ratings and Reviews” and “Write a Review” then a quick line with your favorite part of the episode. It only takes a second and it helps spread the word about the podcast. Supporting Resources: Join the Commerce Cloud Community: http://sforce.co/commercecrew To learn more about Commerce Cloud Innovations, go here: https://www.salesforce.com/commerce/innovations/  Would you like to be on the podcast, or do you know someone who should? Check out the nomination form: http://sfdc.co/podnomination  *** Episode Credits If you like this podcast and are thinking of creating your own, consider talking to my producer, Emerald City Productions. They helped me grow and produce the podcast you are listening to right now. Find out more at https://emeraldcitypro.com. Let them know I sent you.

Two years after the announcement that Veeva and Salesforce would part ways, Life Sciences organizations are racing to evaluate their options and select their CRM partner before the 2025 cutover. Jen is joined by Vynamic's Life Sciences Commercial Operations Lead, Jeremy Shirey, and Tech & Digital Transformation Service Lead, Vince Annerhed-Harris as well as special guests, CodeScience's CEO, Mike Utell, and Chief Revenue Officer, Sean Hogan, to discuss how Life Sciences leaders should approach this decision and transition to minimize disruption and maximize business value.For more information about CodeScience, visit their website: https://www.codescience.com/For more information about Vynamic's work in Commercial Operations and Tech & Digital Transformation, visit: https://vynamic.com/ Podcast Tags: healthcare, life sciences, healthcare technology, healthcare news, Veeva, Salesforce, tech and digital transformation, CRM, commercial operations, CodeSciencePanel – Jen Burke, Jeremy Shirey, Vince Annerhed-Harris, Mike Utell, Sean HoganResearch & Production – Jen Burke, Jeremy Shirey, Vince Annerhed-HarrisRecording & Editing – Mike Liberto, Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Louis Zweig, Southen Glazer's Wine & Spirits SVP of Commercial Operations, dives into the buzz around celebrity brands and why they're shaking up the beverage world. He speaks about championing craft brands and the innovation they bring, highlights market diversity, & shares his incredible journey through the beverage world

Zandy Forbes, Founder, President, and CEO of MeiraGTx, joins host Rahul Chaturvedi in this compelling episode. Zandy shares her inspiring journey from academia, where she developed a deep interest in molecular biology and genetics, to her significant role in biotech investing, and eventually leading a groundbreaking gene therapy company. She elaborates on Meira's cutting-edge approach to genetic medicines, focusing on the development of innovative therapies for non-inherited diseases. Zandy discusses the unique challenges and opportunities that arise in the biotech sector, shedding light on the strategies Meira employs to navigate this complex landscape. Biography: Alexandria Forbes, Ph.D. is the President and CEO of MeiraGTx (NASDAQ: MGTX). MeiraGTx is a vertically integrated gene therapy company with core capabilities in viral vector design and optimization and gene therapy manufacturing, as well as a potentially transformative gene regulation technology. The company is developing innovative gene therapy products to cost effectively treat a range of serious medical disorders, with clinical programs currently in the eye, salivary gland and CNS. Prior to founding MeiraGTx, Dr. Forbes served as Senior Vice President of Commercial Operations at Kadmon Holdings, Inc., a biopharmaceutical company, from September 2013 to April 2015.Before joining the biotech industry, she spent 10 years as a healthcare investor at Sivik Global Partners (Argus Partners) and Meadowvale Partners. At Sivik, Dr. Forbes was responsible for investments in biotechnology, specialty pharmaceuticals and diagnostics public equities and was portfolio manager of the Sivik Global Life Science Fund, a long-biased public markets fund investing in biotechnology companies globally. During her time as a biotechnology investor, Dr. Forbes covered over 300 companies and gained expertise in biotechnology business strategies and clinical drug development as well as a wide range of disease areas. Particular areas of focus included HIV, HCV, diabetes, obesity, autoimmune disorders, cancer, Alzheimer's disease, kidney disease and liver disease. Before entering the hedge fund industry, Dr. Forbes was an academic scientist studying the regulation of stem cell identity and different aspects of embryogeneis. She was a Human Frontiers/Howard Hughes postdoctoral fellow at the Skirball Institute of Biomolecular Medicine at NYU Langone Medical Center, where her research focused on cytoplasmic determinants and cell signaling pathways involved in the migration, establishment and maintenance of germ line stem cells in Drosophila melanogaster. Prior to this, Dr. Forbes was a research fellow at Duke University and at the Carnegie Institute at Johns Hopkins University where she studied the role of the hedgehog gene and its signaling pathway in the Drosophila embryo and adult. Dr. Forbes received her Ph.D. in Molecular Genetics from Oxford University, UK and attained a double first degree in Natural Sciences from Cambridge University, UK. Dr. Forbes serves on the Board of Directors of MeiraGTx, and as a Trustee and Director of the Selfridges Group Foundation, the European arm of the Weston Brain Institute, a charity supporting research into neurodegenerative diseases with the aim of speeding the time to the development of disease modifying treatments for these currently intractable diseases, particularly Alzheimer's.

The concept of an ESOP to me has always seemed extraordinary yet at the same time a little hard to grasp. E-S-O-P is an acronym for Employee Stock Ownership Plan. Basically it means an employee owned company. Our guest on today's podcast is Rich Gaffney, Vice President of Commercial Operations at Sentry Equipment, a 100-year-old [...] The post What If The Employees Owned Your Company?, with Rich Gaffney–EP 220 first appeared on Today's Machining World.

All in 24 Minutes or less… In Season 5, Episode 2, Travis sits down with Kurt Hunzeker, Executive Vice President of Commercial Operations at the National Lacrosse League. Kurt has gained a great amount of experience in brand, team, and league side of the business. Tune in to hear all of the excitement that is surrounding the sport of lacrosse. 3 Hot Topics: ✅ Sharing Best Practices ✅ Key Characteristics  ✅ Future of the NLL www.52weeksofhustle.com Book Available - https://www.amazon.com/dp/1735610801 Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode of BRAVE COMMERCE, Mir Zaman, Vice President of Commercial Operations at Spectrum Brands, joins hosts Rachel Tipograph and Sarah Hofstetter to provide insights on leadership, innovation, and adaptability, offering strategies for navigating dynamic business landscapes effectively.The discussion starts with Mir introducing Spectrum Brands, a company operating in three diverse industries: Home and Personal Care, Home and Garden, and Pet Care. He highlights key brands in the company's portfolio, providing context for understanding the extensive range of consumer products offered by Spectrum Brands.The conversation then delves into Mir's unconventional career path, beginning with his childhood dream of working in aerospace engineering, to roles at Boeing, NASA, and eventually Amazon. His transition into the eCommerce realm at Amazon, despite initial reservations, highlights his adaptability and problem-solving prowess, both integral to his leadership philosophy.Mir emphasizes the significance of curiosity, data-driven decision-making, and a commitment to continuous experimentation in navigating complex business landscapes. He also reflects on the seamless integration of his experiences into his current role at Spectrum Brands, highlighting the importance of augmenting organizational cultures rather than imposing radical transformations.In conclusion, Mir talks about his strategic vision for Spectrum Brands and his focus on fostering collaboration across teams and aligning efforts with overarching business objectives. He also shares insights into decision-making frameworks, akin to an engineering approach, that prioritize inputs and outputs to achieve desired outcomes.Key Takeaways:● Embrace curiosity as a leadership skill for problem-solving and innovation● Empower teams with ownership and accountability tied to revenue and cost objectives● Apply a profit and loss mindset to decision-making, analyzing inputs and outputs to determine the best course of action Hosted on Acast. See acast.com/privacy for more information.